Haemonetics Corp/ US4050241003 /
2024-05-24 10:10:00 PM | Chg. -0.30 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
88.34USD | -0.34% | 644,754 Turnover: 24.54 mill. |
88.01Bid Size: 100 | 88.58Ask Size: 100 | 4.49 bill.USD | - | 38.92 |
Assets
|
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 161.6000 | 257 | 271.4370 | 321.9480 | 337.6340 | ||||||
Intangible Assets | 96.5000 | 264.4000 | 271.1590 | 244.5880 | 204.4580 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | 891.2020 | 915.1400 | 831.0420 | ||||||
Inventories | 117.2000 | 183.8000 | 197.6610 | 211.0770 | 187.0280 | ||||||
Accounts Receivable | 135.5000 | 170.1000 | 164.6030 | 145.8270 | 157.0930 | ||||||
Cash and Cash Equivalents | 228.9000 | 179.1000 | 192.4690 | 160.6620 | 115.1230 | ||||||
Current Assets | 527.1000 | 597 | 622.9760 | 570.2770 | 488.0860 | ||||||
Total Assets | 911.1000 | 1,461.9000 | 1,514.1780 | 1,485.4170 | 1,319.1280 |
Liabilities
|
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 35.4000 | 49.9000 | 53.5620 | 48.4250 | 39.6740 | ||||||
Long-term debt | - | - | 392.0570 | 406.3690 | 364.5290 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 23.3000 | 29.6000 | 29.7000 | 32.1000 | 21.4000 | ||||||
Liabilities | 178.5000 | 692.7000 | 676.2900 | 659.2950 | 597.5630 | ||||||
Share Capital | .5060 | .5100 | .5200 | .5170 | .5090 | ||||||
Total Equity | 732.6000 | 769.2000 | 837.8880 | 826.1220 | 721.5650 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 911.1000 | 1,461.9000 | 1,514.1780 | 1,485.4170 | 1,319.1280 |
Income Statement
|
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 727.9000 | 892 | 938.5090 | 910.3730 | 908.8320 | ||||||
Depreciation (total) | - | - | 81.7400 | 86.0530 | 89.9110 | ||||||
Operating Result | 88.8000 | 56.5000 | 47.3270 | 40.5400 | -43.9420 | ||||||
Interest Income | - | - | -10.9260 | -9.3750 | -9.4740 | ||||||
Income Before Taxes | 89.5000 | 49.9000 | 36.4010 | 31.1650 | -53.4160 | ||||||
Income Taxes | 22.6000 | 11.1000 | 1.2530 | 14.2680 | 2.1630 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 66.9000 | 38.8000 | 35.1480 | 16.8970 | -55.5790 |
Per Share
Cash Flow
|
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 115.3000 | 85.1000 | 139.5240 | 127.1780 | 121.8650 | ||||||
Cash Flow from Investing Activities | -52.2000 | -596.4000 | -105.8300 | -121.7680 | -104.7680 | ||||||
Cash Flow from Financing | -30.5000 | 461.9000 | -20.7000 | -33.1600 | -62.6240 | ||||||
Decrease / Increase in Cash | 32.2000 | -49.7000 | 13.3490 | -31.8070 | -45.5390 | ||||||
Employees | 2,337 | 3,563 | 3,782 | 3,383 | 3,225 |